Mysterious kidney disease strikes young, healthy Texas workers
A mysterious disease is causing acute kidney failure in young, previously healthy workers in Texas, raising concerns about an unknown environmental or occupational exposure.
health
Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
HIGH confidence
Coverage (16189 articles)
GLP-1 Weight Loss Drugs: Separating Science from Hype on Side Effects
Multiple news outlets examine GLP-1 drugs like Ozempic, exploring what actually happens during weight loss, reported side effects like hair loss, and emerging concerns about unsafe 'microdosing' trends on social media.
Long-Term Viability of GLP-1 Obesity Drugs Remains Open Question
Medical experts examine whether GLP-1 drugs like Ozempic can provide lasting obesity treatment and address emerging concerns about side effects including hair loss and metabolic changes.
Key experts withdraw from Letby defence over scientific credibility concerns
Two leading scientists have quit Lucy Letby's defence team citing concerns about the scientific credibility of some arguments, as a public inquiry into the neonatal deaths prepares to report.
Smartphone imaging shows 96% agreement with in-person cataract referrals in rural India
Researchers found 96% agreement between remote ophthalmologists reviewing smartphone images and in-person doctors for cataract referral decisions, potentially expanding eye care access to underserved rural communities.
Engineered heart tissue reveals fibroblast-cardiomyocyte crosstalk in hypertrophic cardiomyopathy
Researchers using engineered micro-heart tissue discovered that communication between fibroblasts and cardiomyocytes is critical to hypertrophic cardiomyopathy disease progression, suggesting more sophisticated models are needed for understanding the condition.
DRC Ebola outbreak peaks as daily cases decline from 120 to 80
DRC authorities announce the Bundibugyo Ebola outbreak has peaked with daily cases dropping from 120 to 80, though nearly 3,500 deaths recorded and experts urge continued vigilance.
DRC Ebola outbreak peaks as infection rates slow, authorities report
Authorities report the Ebola outbreak in the Democratic Republic of Congo has peaked with over 7,200 cases, as infection transmission rates show signs of slowing.
Pharmac proposes streamlined access to medicines for hypertension and resistant infections
Pharmac proposes funding one new medicine and widening access to three existing treatments for high blood pressure and bacterial infections, moving them from individual application processes to standard pharmaceutical schedules.
Hospital madrileño manipula gravedad de pacientes para reducir lista de espera quirúrgica
Un importante hospital de Madrid habría alterado artificialmente la clasificación de gravedad de pacientes quirúrgicos para maquillar sus listas de espera, según reporta El País.
Hospital Ramón y Cajal alteró la gravedad de pacientes para maquillar listas de espera quirúrgica
Directivos del Hospital Ramón y Cajal rebajaron informáticamente la prioridad de 57 pacientes quirúrgicos sin consultar a los cirujanos, para cumplir objetivos de productividad y mejorar artificialmente sus listas de espera.
Researchers investigate cancer cluster in California community amid pesticide concerns
Researchers are investigating a rare cancer cluster in Ladera Ranch, California, where multiple cases of Ewing sarcoma have been identified. Environmental testing of soil and water is underway to determine potential causes.
Ivonescimab Extends Survival in Advanced Lung Cancer vs. Pembrolizumab
Ivonescimab demonstrated significant overall survival improvement versus pembrolizumab in advanced non-small cell lung cancer patients, with median survival of 30.8 months versus 22.6 months in the phase 3 HARMONi-2 trial.
Ris-Rez Shows 54% Survival Benefit Over Standard Treatment in Relapsed Lung Cancer
Phase III trial results show risvutatug rezetecan (Ris-Rez) nearly doubled overall survival to 18.5 months versus 10.3 months with topotecan in patients with relapsed small-cell lung cancer.
Pharma's future demands empathy alongside science, says Menarini APAC CMO
Menarini's APAC CMO advocates balancing scientific rigor with creativity, empathy and cultural relevance in pharmaceutical marketing, moving beyond traditional product-focused approaches.
Tirzepatide and semaglutide show similar asthma outcomes despite metabolic differences
A US study of 16,352 adults with asthma and type 2 diabetes found tirzepatide and semaglutide produced similar asthma exacerbation risks over 12 months, despite tirzepatide's greater metabolic benefits.
FCT reports no new diphtheria cases as outbreak response continues
FCT epidemiologist confirms no new diphtheria cases since recent outbreak that killed two and infected five. Enhanced surveillance and public sensitization ongoing across territory.
8-Hour Eating Window Shows Weight Loss Edge, But Metabolic Benefits Remain Unclear
A pooled analysis of five trials found 8-hour time-restricted eating produced greater weight loss than longer windows, but cardiometabolic benefits were inconsistent and effects weakened after statistical adjustment.
Perioperative Immunotherapy Reshapes Genitourinary Cancer Treatment Landscape
Oncologists at Binaytara 2026 conference highlighted emerging treatments for bladder, prostate, and kidney cancers, with perioperative immunotherapy combinations and biomarker-directed approaches reshaping clinical practice.
Thirlwall Inquiry into Lucy Letby case publishes findings on hospital failures
A public inquiry into how nurse Lucy Letby murdered and harmed babies at a UK hospital is publishing findings on systemic failures and whether earlier action could have prevented deaths.
Testosterone Therapy Shows No Benefit for Women With Early Heart Failure
A randomized controlled trial found testosterone therapy did not improve exercise capacity or quality of life in postmenopausal women with early heart failure, despite biologically plausible rationale.
Estudio finlandés detecta cambios en rodillas desde los 33 años sin dolor aparente
Estudio finlandés detecta alteraciones en cartílago y crecimientos óseos en rodillas de adultos de 33 años sin dolor. El índice de masa corporal elevado se asocia con mayor presencia de anomalías articulares.
Korean trial shows extended aspirin use cuts heart attack risk after stenting
Korea's A-CLOSE trial shows continuing aspirin with clopidogrel after coronary stenting provides better protection against ischemic events in high-risk patients, despite increased bleeding risk, offering clinicians evidence to individualize long-term treatment decisions.
Swedish study reveals AAV patients face 2x higher cardiovascular and clot risk
A Swedish nationwide study of over 4,000 AAV patients found they face approximately twice the risk of cardiovascular disease and blood clots compared to the general population, with highest danger in months around diagnosis.